1. Home
  2. BGLC vs ICCT Comparison

BGLC vs ICCT Comparison

Compare BGLC & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • ICCT
  • Stock Information
  • Founded
  • BGLC N/A
  • ICCT 1992
  • Country
  • BGLC Malaysia
  • ICCT United States
  • Employees
  • BGLC 30
  • ICCT N/A
  • Industry
  • BGLC Medical Specialities
  • ICCT Computer Software: Prepackaged Software
  • Sector
  • BGLC Health Care
  • ICCT Technology
  • Exchange
  • BGLC Nasdaq
  • ICCT Nasdaq
  • Market Cap
  • BGLC 9.2M
  • ICCT 9.1M
  • IPO Year
  • BGLC N/A
  • ICCT N/A
  • Fundamental
  • Price
  • BGLC $0.53
  • ICCT $0.80
  • Analyst Decision
  • BGLC
  • ICCT
  • Analyst Count
  • BGLC 0
  • ICCT 0
  • Target Price
  • BGLC N/A
  • ICCT N/A
  • AVG Volume (30 Days)
  • BGLC N/A
  • ICCT 28.0K
  • Earning Date
  • BGLC N/A
  • ICCT 08-08-2024
  • Dividend Yield
  • BGLC N/A
  • ICCT N/A
  • EPS Growth
  • BGLC N/A
  • ICCT N/A
  • EPS
  • BGLC N/A
  • ICCT N/A
  • Revenue
  • BGLC N/A
  • ICCT $9,034,579.00
  • Revenue This Year
  • BGLC N/A
  • ICCT N/A
  • Revenue Next Year
  • BGLC N/A
  • ICCT N/A
  • P/E Ratio
  • BGLC N/A
  • ICCT N/A
  • Revenue Growth
  • BGLC N/A
  • ICCT 16.06
  • 52 Week Low
  • BGLC N/A
  • ICCT $0.81
  • 52 Week High
  • BGLC N/A
  • ICCT $10.60
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 58.76
  • ICCT 41.76
  • Support Level
  • BGLC $0.50
  • ICCT $0.81
  • Resistance Level
  • BGLC $0.55
  • ICCT $0.90
  • Average True Range (ATR)
  • BGLC 0.03
  • ICCT 0.06
  • MACD
  • BGLC 0.01
  • ICCT -0.00
  • Stochastic Oscillator
  • BGLC 78.84
  • ICCT 17.59

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About ICCT iCoreConnect Inc. Common stock

iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.

Share on Social Networks: